| 12/12/2024 |
Nichi-Iko and Fujitsu drive pharmaceutical manufacturing DX with AI |
| 02/28/2023 |
Notice Regarding Change in the Company's Consolidated Subsidiary |
| 02/13/2023 |
Extraordinary General Meeting of Shareholders Notice of Convocation |
| 01/25/2023 |
Notice Regarding Convocation of the Extraordinary General Meeting of Shareholders and Decision on Agenda Proposals, Capital Reduction, Appropriation of Surplus, Change in Representative Board Member, and Officer Appointments |
| 12/29/2022 |
Notice Regarding Convening of Creditors' Meeting for Resolution of Proposed Business Turnaround Plan in Business Turnaround ADR, Completion of Business Turnaround ADR, and Financial Support including Debt Forgiveness |
| 12/09/2022 |
Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2023 (IFRS) |
| 11/25/2022 |
Notice Regarding Change in Representative Board Member |
| 11/25/2022 |
Notice Regarding Issuance of New Shares by Third-Party Allotment, Partial Amendment of Articles of Incorporation, Share Consolidation, Abolition of Provisions on Share Units, Reduction of Capital and Capital Reserve Amounts, Appropriation of Surplus, and |
| 09/09/2022 |
Consolidated Financial Results for the 1st Quarter of the Fiscal Year Ending March 31, 2023(IFRS) |
| 06/30/2022 |
Consolidated Financial Results for the Fiscal Year Ended March 31, 2022 (IFRS) |
